Trading Halt

150722_Trading Halt

Recent Articles

200921_PharmAust Awarded FightMND Grant for Phase I Trial
September 21, 2020
14 September, Shareholder Update
September 14, 2020
Elanco not to Exercise Agreed Option
September 9, 2020
Monepantel Anti-Covid-19 Activity Confirmed
September 9, 2020

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

PharmAustFollow

Retweet on Twitter PharmAust Retweeted

Brad Turner @turnerMNDlab·

2h

Exciting news about a world-first trial of monepantel for #MND #ALS in Australia. https://twitter.com/pharmaust/status/1307832264269598720

PharmAust@PharmAust

PharmAust receives grant from FightMND for monepantel phase one trial in motor neuron disease https://smallcaps.com.au/pharmaust-fightmnd-monepantel-phase-one-trial-motor-neuron-disease/ via @SmallCapsASX

Reply on Twitter 1307873727913193474 Retweet on Twitter 13078737279131934741 Like on Twitter 13078737279131934748 Twitter 1307873727913193474

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top